Real-time enrollment status for this infiltrating bladder urothelial carcinoma with squamous differentiation clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:10 PM UTC
| NCT Number | NCT04878029 |
| Recruiting Status | Recruiting |
| Condition | Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation |
| Phase | PHASE1 |
| Target Enrollment | 32 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Emory University |
| Last Updated on CT.gov | April 29, 2026 (Apr 29, 2026) |
As of July 18, 2026: Clinical trial NCT04878029 is currently recruiting participants. This phase1 study for infiltrating bladder urothelial carcinoma with squamous differentiation is actively seeking new participants at 1 location across the United States. The study is sponsored by Emory University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04878029 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04878029 was last updated Apr 29, 2026 (April 29, 2026). HelloStudys verifies this status automatically.